At the time of study start 30 (91%) patients were treated with an ACE-inhibitor or angiotensin ll-receptor-blocker, 20 (61%) patients received diuretics, 15 (45%) patients received statins and five (15%) patients received anticoagulants, although they had non-nephrotic proteinuria. This evidence concerns the gene ACE and Proteinuria.